Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HUMAN INTERLEUKIN-2 VARIANT AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/005680
Kind Code:
A1
Abstract:
Provided are a human interleukin-2 variant and the use thereof. Specifically, provided is an IL-2 variant (or a derivative thereof) having eliminated or reduced affinity with a high-affinity receptor IL-2Rα/β/γ and retaining affinity with a medium-affinity receptor IL-2Rβ/γ. Also provided is a recombinant protein/fusion protein comprising an IL-2 variant and a human antibody fragment. The activity of the IL-2 variant is improved, and is close to the activity of a wild human IL-2.

Inventors:
DONG MINGHUI (CN)
LU YONGTAO (CN)
LIU JIANGUANG (CN)
Application Number:
PCT/CN2022/105789
Publication Date:
February 02, 2023
Filing Date:
July 14, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
XIAN LONGTENGJINGYUN BIOTECHNOLOGY CO LTD (CN)
YUNQUAN BIOTECHNOLOGY BEIJING CO LTD (CN)
International Classes:
C07K14/55; A61K38/20; A61K47/68; A61P35/00; A61P37/00; C07K19/00; C12N15/62; C12N15/64; C12N15/70; C12N15/81
Domestic Patent References:
WO2020125743A12020-06-25
WO2009135615A22009-11-12
WO2012062228A22012-05-18
Foreign References:
CN114369153A2022-04-19
CN111647068A2020-09-11
CN113831402A2021-12-24
CN112105633A2020-12-18
CN104231068A2014-12-24
CN202110868409A2021-07-30
CN202210621425A2022-06-01
US8906356B22014-12-09
US9732134B22017-08-15
US7803361B22010-09-28
US8124066B22012-02-28
Other References:
CHANG RUIXUE, YAN TIAN-HUA, WANG QIU-JUAN, GUO QING-LONG: "Advances in Application of Interleukin-2 and Its Related Drugs ", PROGRESS IN PHARMACEUTICAL SCIENCES, CHINA PHARMACEUTICAL UNIVERSITY, CN, vol. 35, no. 1, 25 January 2011 (2011-01-25), CN , pages 1 - 7, XP093028922, ISSN: 1001-5094, DOI: 10.3969/j.issn.1001-5094.2011.01.001
"Genbank", Database accession no. NP_000577.2
Attorney, Agent or Firm:
GE CHENG & CO., LTD (CN)
Download PDF: